BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Seongil Jo

Seongil Jo contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
Applicationsmath.STMethodologyStatistics Theory

Trust snapshot

Quick read

Trust 15 - UnverifiedVerification L1Unclaimed author
3works
0followers
4topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2022arXiv

Estimation of World Seroprevalence of SARS-CoV-2 antibodies

In this paper, we estimate the seroprevalence against COVID-19 by country and derive the seroprevalence over the world. To estimate seroprevalence, we use serological surveys (also called the serosurveys) conducted within each country. When the serosurveys are incorporated to estimate world seroprevalence, there are two issues. First, there are countries in which a serological survey has not been conducted. Second, the sample collection dates differ from country to country. We attempt to tackle these problems using the vaccination data, confirmed cases data, and national statistics. We construct Bayesian models to estimate the numbers of people who have antibodies produced by infection or vaccination separately. For the number of people with antibodies due to infection, we develop a hierarchical model for combining the information included in both confirmed cases data and national statistics. At the same time, we propose regression models to estimate missing values in the vaccination data. As of 31st of July 2021, using the proposed methods, we obtain the 95% credible interval of the world seroprevalence as [38.6%, 59.2%].

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Seroprevalence of SARS-CoV-2 antibodies in South Korea

In $2020$, Korea Disease Control and Prevention Agency reported three rounds of surveys on seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in South Korea. We analyze the seroprevalence surveys using a Bayesian method with an informative prior distribution on the seroprevalence parameter, and the sensitivity and specificity of the diagnostic test. We construct the informative prior using the posterior distribution obtained from the clinical evaluation data based on the plaque reduction neutralization test. The constraint of the seroprevalence parameter induced from the known confirmed coronavirus 2019 cases can be imposed naturally in the proposed Bayesian model. We also prove that the confidence interval of the seroprevalence parameter based on the Rao's test can be the empty set, while the Bayesian method renders a reasonable interval estimator. As of the $30$th of October $2020$, the $95\%$ credible interval of the estimated SARS-CoV-2 positive population does not exceed $307,448$, approximately $0.6\%$ of the Korean population.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

The Beta-Mixture Shrinkage Prior for Sparse Covariances with Posterior Minimax Rates

Statistical inference for sparse covariance matrices is crucial to reveal dependence structure of large multivariate data sets, but lacks scalable and theoretically supported Bayesian methods. In this paper, we propose beta-mixture shrinkage prior, computationally more efficient than the spike and slab prior, for sparse covariance matrices and establish its minimax optimality in high-dimensional settings. The proposed prior consists of beta-mixture shrinkage and gamma priors for off-diagonal and diagonal entries, respectively. To ensure positive definiteness of the resulting covariance matrix, we further restrict the support of the prior to a subspace of positive definite matrices. We obtain the posterior convergence rate of the induced posterior under the Frobenius norm and establish a minimax lower bound for sparse covariance matrices. The class of sparse covariance matrices for the minimax lower bound considered in this paper is controlled by the number of nonzero off-diagonal elements and has more intuitive appeal than those appeared in the literature. The obtained posterior convergence rate coincides with the minimax lower bound unless the true covariance matrix is extremely sparse. In the simulation study, we show that the proposed method is computationally more efficient than competitors, while achieving comparable performance. Advantages of the shrinkage prior are demonstrated based on two real data sets.

0 citations0 reviewsNo code linkedOpen access